Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Last year, the minivan only made up 1.8% of auto sales but more and more people are interested in purchasing the comfortable, multi-seater. Cheddar News looks back at the evolution and history of the minivan.
Americans said credit was harder to access last month, according to a survey from the New York branch of the Federal Reserve. The March Survey of Consumer Expectations found that “respondents were more pessimistic about future credit availability as well, with the share of households expecting it will be harder to obtain credit a year from now also rising.”
Wall Street drifted through a muted day of trading Tuesday, with stocks and bonds making modest moves ahead of reports later in the week with the potential to move markets.
Cheddar News breaks down what to expect on The Day Ahead, as earnings from Albertsons and Carmax are on tap to be released while Fed minutes are due on Wednesday ahead of its meeting next month.
